Manufacturers seeking to apply these procedures need to give robust validation details to display their equivalence to pharmacopoeial methods. As these new technologies arise, the WHO emphasizes the value of an intensive risk evaluation and validation approach. An overpressure (ten to 100 Pa) prevails from the sterile test isolator to cir